FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

BAE Systems upgrades 2025 outlook after strong H1 performance

BAE Systems reported an 11% rise in H1 sales to £14.6bn and a 13% increase in underlying EBIT to £1.55bn, prompting an upgrade to full-year sales and profit guidance...

Sage Group Plc reports 9% revenue growth, reaffirms FY25 outlook

Sage Group (LON:SGE) reported a 9% year-on-year rise in total revenue to £1.86bn for the nine months to 30 June 2025. Strong growth was driven by Sage Business Cloud (+13%) and recurring revenue (+10%)...

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%). Core EPS rose 15% to 46.5p...

Glencore delivers 5% H1 CuEq growth and $1bn cost savings plan

Glencore has reported a 5% year-on-year increase in copper equivalent production for H1 2025, driven by the integration of EVR’s steelmaking coal volumes. Copper output declined due to planned sequencing, cobalt and zinc production rose...

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m...

Entain’s BetMGM delivers 36% revenue growth and raises FY25 guidance

BetMGM LLC reported 2Q 2025 net revenue of $692 million, up 36% year‑on‑year, with EBITDA of $86 million (up $78 million) and 1H net revenue of $1.35 billion (up 35%) with EBITDA of $109 million (up $232 million)...

Barclays Plc H125 Interim Results: RoTE 13.2% and £1.4 bn capital distributions

Barclays delivered a profit before tax of £5.2 bn and a return on tangible equity of 13.2 per cent in the first half of 2025, with income up 12 per cent to £14.9 bn and EPS rising to 24.7 p...

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence (ex‑China) for HRS‑9821, a potential best‑in‑class PDE3/4 inhibitor for COPD, for $500 million in upfront fees and up to $12 billion in milestone payments...

NatWest Group Plc reports H1 2025 profit rise of 28%, dividend up 58%

NatWest Group delivered an attributable profit of £2.5 billion in H1 2025, with earnings per share up 28% to 30.9 pence, Return on Tangible Equity of 18.1% and a cost:income ratio improved to 48.8%...

Rightmove reports strong H1 2025; 10% revenue rise and strategic growth

Rightmove plc today announces unaudited results for the six months to 30 June 2025, with revenue up 10% to £211.7 million, operating profit up 10% to £145.4 million and strategic growth area delivering a combined 37% year-on-year increase as partner retention hits a decade high and AI-driven innovation accelerates...

Centrica H1 2025 interim results: EBITDA £900 m, dividend +22%

Centrica delivered resilient H1 2025 performance with adjusted EBITDA of £900 m and free cash flow of £244 m, while net cash stood at £2.5 bn..

Anglo American reports iron ore and manganese surge in Q2

In Q2 2025, copper production reached 173 kt, down 11% year‑on‑year but up 3% quarter‑on‑quarter, iron ore output rose 2% to 15.9 Mt and manganese surged 109% after operations resumed...

Weir Group Plc retains CDP 2024 climate A-list status

Weir Group kept its CDP ‘A’ rating for climate transparency and performance in 2024. The company targets net zero by 2050 and outlined four priorities: energy-efficient tech, low-carbon energy access for mining regions, smarter water use and revised targets...

Fresnillo Plc reports stronger gold, steady silver, guidance maintained

Silver output was 12.5moz, up 1% on Q1 but down 14.7% year on year, while gold rose 21.3% to 157.7koz. 2025 production guidance is maintained and interim results will be released on 5 August 2025...

Informa delivers 20%+ reported growth, with revenue at £2,035.9m

Informa delivered 20%+ reported growth, and adjusted operating profit up 24% to £578.9m, lifting margin to 28.4%. Full year guidance was upgraded and an additional £150m buyback confirmed, taking 2025 repurchases to £350m...

Centrica Plc to take 15% stake in Sizewell C with £1.3bn commitment

Centrica will acquire a 15% equity stake in Sizewell C, committing up to £1.3bn under the RAB model. The deal targets a 10.8% allowed ROE and an IRR above 12%, with Revenue Commencement expected in Q4 2025...

AstraZeneca to invest $50bn in the US, new Virginia manufacturing site planned

AstraZeneca will invest $50bn in the United States by 2030, including a multi‑billion dollar drug substance facility in Virginia for its weight management and metabolic portfolio...

Compass Group to acquire Vermaat for c.€1.5bn, widening its premium offer in Europe

Compass Group will buy Vermaat Groep for an enterprise value of about €1.5bn. Vermaat is targeting c.€700m sales in 2025 with a double-digit operating margin...

bp Plc appoints Albert Manifold as new Chair

BP will welcome Albert Manifold to its board as chair‑elect on 1 September, with Helge Lund stepping down and Manifold becoming chair on 1 October. Bringing a track record of strategic leadership and cash‑flow focus from his tenure at CRH, he will steer BP’s next phase of performance and value creation...
Search

Funds

FTSE 100

BAE Systems upgrades 2025 outlook after strong H1 performance

BAE Systems reported an 11% rise in H1 sales to £14.6bn and a 13% increase in underlying EBIT to £1.55bn, prompting an upgrade to full-year sales and profit guidance...

Sage Group Plc reports 9% revenue growth, reaffirms FY25 outlook

Sage Group (LON:SGE) reported a 9% year-on-year rise in total revenue to £1.86bn for the nine months to 30 June 2025. Strong growth was driven by Sage Business Cloud (+13%) and recurring revenue (+10%)...

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%). Core EPS rose 15% to 46.5p...

Glencore delivers 5% H1 CuEq growth and $1bn cost savings plan

Glencore has reported a 5% year-on-year increase in copper equivalent production for H1 2025, driven by the integration of EVR’s steelmaking coal volumes. Copper output declined due to planned sequencing, cobalt and zinc production rose...

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m...

Entain’s BetMGM delivers 36% revenue growth and raises FY25 guidance

BetMGM LLC reported 2Q 2025 net revenue of $692 million, up 36% year‑on‑year, with EBITDA of $86 million (up $78 million) and 1H net revenue of $1.35 billion (up 35%) with EBITDA of $109 million (up $232 million)...

Barclays Plc H125 Interim Results: RoTE 13.2% and £1.4 bn capital distributions

Barclays delivered a profit before tax of £5.2 bn and a return on tangible equity of 13.2 per cent in the first half of 2025, with income up 12 per cent to £14.9 bn and EPS rising to 24.7 p...

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence (ex‑China) for HRS‑9821, a potential best‑in‑class PDE3/4 inhibitor for COPD, for $500 million in upfront fees and up to $12 billion in milestone payments...

NatWest Group Plc reports H1 2025 profit rise of 28%, dividend up 58%

NatWest Group delivered an attributable profit of £2.5 billion in H1 2025, with earnings per share up 28% to 30.9 pence, Return on Tangible Equity of 18.1% and a cost:income ratio improved to 48.8%...

Rightmove reports strong H1 2025; 10% revenue rise and strategic growth

Rightmove plc today announces unaudited results for the six months to 30 June 2025, with revenue up 10% to £211.7 million, operating profit up 10% to £145.4 million and strategic growth area delivering a combined 37% year-on-year increase as partner retention hits a decade high and AI-driven innovation accelerates...

Centrica H1 2025 interim results: EBITDA £900 m, dividend +22%

Centrica delivered resilient H1 2025 performance with adjusted EBITDA of £900 m and free cash flow of £244 m, while net cash stood at £2.5 bn..

Anglo American reports iron ore and manganese surge in Q2

In Q2 2025, copper production reached 173 kt, down 11% year‑on‑year but up 3% quarter‑on‑quarter, iron ore output rose 2% to 15.9 Mt and manganese surged 109% after operations resumed...

Weir Group Plc retains CDP 2024 climate A-list status

Weir Group kept its CDP ‘A’ rating for climate transparency and performance in 2024. The company targets net zero by 2050 and outlined four priorities: energy-efficient tech, low-carbon energy access for mining regions, smarter water use and revised targets...

Fresnillo Plc reports stronger gold, steady silver, guidance maintained

Silver output was 12.5moz, up 1% on Q1 but down 14.7% year on year, while gold rose 21.3% to 157.7koz. 2025 production guidance is maintained and interim results will be released on 5 August 2025...

Informa delivers 20%+ reported growth, with revenue at £2,035.9m

Informa delivered 20%+ reported growth, and adjusted operating profit up 24% to £578.9m, lifting margin to 28.4%. Full year guidance was upgraded and an additional £150m buyback confirmed, taking 2025 repurchases to £350m...

Centrica Plc to take 15% stake in Sizewell C with £1.3bn commitment

Centrica will acquire a 15% equity stake in Sizewell C, committing up to £1.3bn under the RAB model. The deal targets a 10.8% allowed ROE and an IRR above 12%, with Revenue Commencement expected in Q4 2025...

AstraZeneca to invest $50bn in the US, new Virginia manufacturing site planned

AstraZeneca will invest $50bn in the United States by 2030, including a multi‑billion dollar drug substance facility in Virginia for its weight management and metabolic portfolio...

Compass Group to acquire Vermaat for c.€1.5bn, widening its premium offer in Europe

Compass Group will buy Vermaat Groep for an enterprise value of about €1.5bn. Vermaat is targeting c.€700m sales in 2025 with a double-digit operating margin...

bp Plc appoints Albert Manifold as new Chair

BP will welcome Albert Manifold to its board as chair‑elect on 1 September, with Helge Lund stepping down and Manifold becoming chair on 1 October. Bringing a track record of strategic leadership and cash‑flow focus from his tenure at CRH, he will steer BP’s next phase of performance and value creation...
Search

Funds

FTSE 100

FTSE 100

Funds